Senator Marshall Slams PBM Price Gouging Tactics in Ozempic and Wegovy Drug Pricing Hearing
September 24, 2024
September 24, 2024
WASHINGTON, Sept. 24 -- Sen. Roger Marshall, R-Kansas, issued the following news release:
Senator Roger Marshall, M.D. questioned the CEO of Novo Nordisk, the company that created the blockbuster drugs Ozempic (semaglutide) and Wegovy (semaglutide). As part of the Health, Education, Labor, and Pensions Committee hearing on drug pricing, Senator Marshall questioned the CEO about the role that Pharmacy Benefit Managers (PBMs) play in inflating the prices of essential drugs. His series . . .
Senator Roger Marshall, M.D. questioned the CEO of Novo Nordisk, the company that created the blockbuster drugs Ozempic (semaglutide) and Wegovy (semaglutide). As part of the Health, Education, Labor, and Pensions Committee hearing on drug pricing, Senator Marshall questioned the CEO about the role that Pharmacy Benefit Managers (PBMs) play in inflating the prices of essential drugs. His series . . .